X

pharmaceuticals

ABBV Infographic: AbbVie’s Q3 earnings beat estimates; revenue up 3%

Pharmaceutical company AbbVie, Inc. (NYSE: ABBV) reported a sharp increase in third-quarter adjusted earnings. The bottom line topped expectations, while…

Infographic: Highlights of Merck’s (MRK) Q3 2022 earnings

Merck & Co., Inc. (NYSE: MRK) reported a modest increase in adjusted earnings for the third quarter of 2022 when…

BIIB Stock: Is Biogen an investment worth trying now?

Biogen Inc. (NASDAQ: BIIB) has been going through a rough patch for some time as the company's popular products faced…

Infographic: Highlights from Biogen’s (BIIB) Q3 2022 earnings results

Pharma giant Biogen Inc. (NASDAQ: BIIB) on Tuesday announced financial results for the third quarter of 2022, reporting a double-digit…

Infographic: Highlights of Intuitive Surgical’s Q3 2022 earnings

Medical device company Intuitive Surgical, Inc. (NASDAQ: ISRG) said its third-quarter adjusted earnings remained unchanged year-over-year, while revenues increased in…

Key highlights from Abbott (ABT) Q3 2022 earnings results

Abbott (NYSE: ABT) reported third quarter 2022 earnings results today. Sales decreased 4.7% year-over-year to $10.4 billion. On an organic…

JNJ Earnings: Johnson & Johnson Q3 adj. profit drops despite higher sales

Johnson & Johnson (NYSE: JNJ) reported a decline in adjusted profit for the third quarter of 2022, despite a modest increase…

Johnson & Johnson (JNJ) offers long-term stability. Is the stock a buy?

Johnson & Johnson (NYSE: JNJ) has stayed largely unaffected by the COVID crisis and macroeconomic headwinds so far, which allowed…

TLRY Earnings: Highlights of Tilray’s Q1 2023 financial results

Cannabis company Tilray (NASDAQ: TLRY) has announced financial results for the first quarter of 2023, reporting a wider net loss…

ANGO Earnings: AngioDynamics Q1 loss widens. Revenue up 6%

AngioDynamics Inc. (NASDAQ: ANGO) on Friday reported a wider loss for the first quarter of 2023, despite a modest increase…

Prime Medicine is the next big biotech to pursue IPO. Here’s all you need to know

After a soft start to the year, the IPO market has witnessed muted activity so far though a few big…

Trxade Health Inc. (NASDAQ: MEDS) Q3 2022 Research Summary

Trxade Health Inc. (NASDAQ: MEDS) is an integrated drug delivery platform that offers a digitalized retail pharmacy experience to independent…

IPO Alert: Third Harmonic files to go public. Here’s what you need to know

IPO activity has started gaining steam after falling significantly in the first half, in line with the global trend, but…

Pfizer (PFE): A look at the headwinds and tailwinds this pharma giant faces in the near term

Shares of Pfizer Inc. (NYSE: PFE) were down on Monday. The stock has dropped 15% year-to-date and there is a…

Trxade will focus more on core biz, connect with POS systems: CEO Suren Ajjarapu

Trxade Health Inc. (NASDAQ: MEDS) has been on a mission to digitalize the retail pharmacy experience by providing a platform…

Eli Lilly and Company (LLY) Earnings: 2Q22 Key Numbers

Eli Lilly and Company (NYSE: LLY) reported second quarter 2022 earnings results today. Worldwide revenue decreased 4% to $6.49 billion compared…

CVS Health Corporation (CVS) Q2 2022 Earnings: Key financials and quarterly highlights

CVS Health Corporation (NYSE: CVS) reported second quarter 2022 earnings results today. Total revenues increased 11% year-over-year to $80.6 billion.…

ABBV Earnings: Highlights of AbbVie’s Q2 2022 financial results

Pharmaceutical company AbbVie, Inc. (NYSE: ABBV) has reported double-digit growth in second-quarter adjusted earnings, reflecting an increase in revenues. The…

Bristol Myers Squibb (BMY) Q2 2022 Earnings: Key financials and quarterly highlights

Bristol Myers Squibb (NYSE: BMY) reported second quarter 2022 earnings results today. Total revenue grew 2% year-over-year to $11.9 billion.…

Pfizer (PFE) Q2 2022 Earnings: Key financials and quarterly highlights

Pfizer Inc. (NYSE: PFE) reported second quarter 2022 earnings results today. Total revenues increased 47% year-over-year to $27.7 billion. Reported…

MEDS Earnings: Trxade Health Q2 revenues surge 73% amid continued user growth

Trxade Health Inc (NASDAQ: MEDS), a leading health service IT company, reported a sharp increase in its second-quarter 2022 revenues.…